What is the appropriate workup for a patient with a vitamin B12 level below 150 pg/mL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Workup After Vitamin B12 Level Returns < 150 pg/mL

When vitamin B12 is confirmed below 150 pg/mL, immediately measure methylmalonic acid (MMA) to confirm functional deficiency, obtain a complete blood count (CBC) with peripheral smear, and test for intrinsic factor antibodies to identify pernicious anemia as the underlying cause. 1, 2

Initial Confirmatory Testing

A vitamin B12 level below 150 pg/mL (or <180 pg/mL by some laboratory standards) confirms absolute deficiency 3, 4. However, you must determine if this represents true functional deficiency and identify the underlying cause:

Essential Laboratory Tests

  • Methylmalonic acid (MMA): This is the most specific confirmatory test for functional B12 deficiency. MMA is elevated in 98.4% of true B12 deficiency cases 2. While expensive (£11-80), it definitively confirms that the low B12 level is causing metabolic dysfunction 3. MMA >0.4 nmol/mL indicates functional deficiency 5.

  • Complete blood count with peripheral smear: Look specifically for:

    • Macrocytic anemia (MCV >100 fL) - though this may be absent in up to 30% of cases 6, 7
    • Hypersegmented neutrophils (>5 lobes)
    • Pancytopenia in severe cases 7
    • Tear-drop cells may indicate severe deficiency 7
  • Intrinsic factor antibodies: Test immediately to diagnose pernicious anemia, the most common cause of severe B12 deficiency requiring lifelong parenteral therapy 1, 8

Additional Etiologic Workup

  • Helicobacter pylori testing: Atrophic gastritis from H. pylori is a common reversible cause 4

  • Anti-parietal cell antibodies: If intrinsic factor antibodies are negative but pernicious anemia is still suspected 4

  • Medication review: Specifically assess for:

    • Metformin use >4 months (7-11% develop deficiency) 1, 9
    • Proton pump inhibitors or H2 blockers >12 months 9, 4
  • Dietary history: Strict vegans/vegetarians are at high risk 1, 9

  • Surgical history: Any gastric or ileal resection >20 cm mandates lifelong supplementation 10, 11

Critical Clinical Assessment

Neurological Examination

This is urgent. B12 deficiency can cause irreversible neurological damage if not treated immediately 8. Examine for:

  • Peripheral neuropathy (numbness, tingling in extremities)
  • Posterior column dysfunction (loss of vibration/position sense)
  • Ataxia and gait disturbance
  • Cognitive impairment or psychiatric symptoms 1, 4

If any neurological symptoms are present, initiate treatment immediately before all test results return 8. Waiting for confirmatory tests risks permanent neurological damage.

Hematologic Manifestations

Beyond anemia, assess for:

  • Glossitis (smooth, beefy red tongue)
  • Jaundice from ineffective erythropoiesis
  • Thrombocytopenia or leukopenia 7

Important Caveats

Do not measure homocysteine alone - while elevated in 95.9% of B12 deficiency, it is also elevated in folate deficiency (91% of cases), pyridoxine deficiency, hypothyroidism, and renal insufficiency, making it non-specific 2. MMA is far superior (only 12.2% false positive rate in isolated folate deficiency) 2.

Check folate levels but never treat with folic acid before confirming and treating B12 deficiency 8, 11. Folate supplementation can mask the hematologic manifestations of B12 deficiency while allowing neurological damage to progress - a potentially catastrophic error 1.

Reticulocyte count helps distinguish production versus destruction: a low reticulocyte index (<2.0) confirms decreased RBC production consistent with B12 deficiency 6.

When MMA Testing Is Not Available

If MMA testing is unavailable or cost-prohibitive, and B12 is <150 pg/mL with compatible clinical features (macrocytic anemia, neurological symptoms, or clear risk factors), proceed directly to treatment 3, 4. The risk of untreated B12 deficiency far outweighs the minimal risks of B12 supplementation.

References

Research

Vitamin B12 Deficiency: Common Questions and Answers.

American family physician, 2025

Guideline

cancer- and chemotherapy-induced anemia.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Research

Vitamin B12 Deficiency: Recognition and Management.

American family physician, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.